Finance

Beta
Lists
001630:KRX
Chongkundang Holdings Corp
₩41,550.00
+1.71%
(+700.00) 1D
Jun 12, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 001630...
Open
₩41,300
High
₩42,350
Low
₩41,100
Mkt. cap
208.16B
Avg. vol.
6.09K
Volume
0.00
Dividend
3.37%
Quarterly dividend
₩350
Ex-dividend date
Mar 30, 2026
P/E ratio
4.23
52-wk high
₩59,300
52-wk low
₩40,050
EPS
₩9,818
Shares outstanding
5.01M
No. of employees
37
Open
₩41,300
High
₩42,350
Low
₩41,100
Mkt. cap
208.16B
Avg. vol.
6.09K
Volume
0.00
Dividend
3.37%
Quarterly dividend
₩350
Ex-dividend date
Mar 30, 2026
P/E ratio
4.23
52-wk high
₩59,300
52-wk low
₩40,050
EPS
₩9,818
Shares outstanding
5.01M
No. of employees
37
News stories
From sources across the web
About Chongkundang Holdings Corp
CEO-
Employees37
FoundedMay 7, 1941
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
242.18B
234.22B
235.99B
240.27B
Cost of goods sold
129.43B
129.67B
138.25B
128.74B
Cost of revenue
129.43B
129.67B
138.25B
128.74B
Research and development expenses
5.47B
6.64B
8.34B
8.66B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
87.23B
75.78B
71.50B
80.05B
Operating expense
96.24B
86.44B
86.63B
91.87B
Total operating expenses
225.67B
216.11B
224.88B
220.61B
Operating income
16.51B
18.11B
11.11B
19.66B
Other non operating income
-2.79B
3.26B
-427.38M
-720.68M
EBT including unusual items
14.82B
28.73B
13.05B
20.56B
EBT excluding unusual items
6.86B
17.32B
6.55B
15.31B
Income tax expense
3.47B
8.68B
-2.02B
2.66B
Effective tax rate
23.41%
30.22%
-15.51%
12.95%
Other operating expenses
626.29M
1.09B
1.68B
582.81M
Net income
10.56B
13.40B
10.53B
12.89B
Net profit margin
4.36%
5.72%
4.46%
5.36%
Earnings per share
-
-
-
-
Interest and investment income
376.35M
200.59M
484.17M
222.40M
Interest expense
-5.02B
-5.10B
-5.27B
-5.32B
Net interest expenses
-4.65B
-4.90B
-4.78B
-5.10B
Depreciation and amortization charges
2.07B
2.06B
1.66B
2.00B
EBITDA
27.41B
29.14B
22.57B
30.87B
Gain or loss from assets sale
-20.00M
-9.93M
-924.00K
381.06M
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more